Urinary angiotensin-converting enzyme 2 in patients with CKD

Nephrology

Volumn 16, Issue 6, 2011, Pages 567-572

  Mizuiri, Sonoo ^a   Aoki, Toshiyuki ^a   Hemmi, Hiromichi ^a   Arita, Michitsune ^a   Sakai, Ken ^a   Aikawa, Atsushi ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

angiotensin converting enzyme 2; chronic kidney disease; enzyme linked immunosorbent assay; urine; western blotting

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN RECEPTOR ANTAGONIST; BIOCHEMICAL MARKER; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIAGNOSTIC VALUE; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMURIA; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; URINALYSIS; WESTERN BLOTTING;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; CREATININE; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; JAPAN; KIDNEY DISEASES; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; PROTEINURIA; UP-REGULATION; YOUNG ADULT;

EID: 80051684129     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2011.01467.x     Document Type: Article

References (31)

1. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ,. A human homolog of angiotensin-converting enzyme: Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 2000; 275: 33238-43.
2. Ingelfinger JR,. Angiotensin-converting enzyme 2: Implications for blood pressure and kidney disease. Curr. Opin. Nephrol. Hypertens. 2009; 18: 79-84.
3. Koitka A, Cooper ME, Thomas MC, Tikellis C,. Angiotensin converting enzyme 2 in the kidney. Clin. Exp. Pharmacol. Physiol. 2008; 35: 420-5. (Pubitemid 351326772)
4. Ferrario CM, Varagic J,. The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function. Am. J. Physiol. Renal. Physiol. 2010; 298: F1297-F1305.
5. Warner FJ, Smith AI, Hooper NM, Turner AJ,. Angiotensin-converting enzyme-2: A molecular and cellular perspective. Cell. Mol. Life Sci. 2004; 61: 2704-13. (Pubitemid 40022431)
6. Warner FJ, Lew RA, Smith AI, Lambert DW, Hooper NM, Turner AJ,. Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells. J. Biol. Chem. 2005; 280: 39353-62. (Pubitemid 41713892)
7. Lew RA, Warner FJ, Hanchapola I, Smith AI,. Characterization of angiotensin converting enzyme-2 (ACE2) in human urine. Int. J. Pept. Res. Ther. 2006; 12: 283-9. (Pubitemid 44035108)
8. Shaltout HA, Westwood BM, Averill DB, et al,. Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: Evidence for ACE2-dependent processing of angiotensin II. Am. J. Physiol. Renal. Physiol. 2007; 29: F82-F91. (Pubitemid 46105246)
9. Wang G, Lai FM, Lai KB, et al,. Urinary mRNA expression of ACE and ACE2 in human type 2 diabetic nephropathy. Diabetologia 2008; 51: 1062-7.
10. Wysocki J, Ye M, Soler MJ, et al,. ACE and ACE2 activity in diabetic mice. Diabetes 2006; 55: 2132-9. (Pubitemid 44509989)
11. Moon JY, Jeong KH, Lee SH, Lee TW, Ihm CG, Lim SJ,. Renal ACE and ACE2 expression in early diabetic rats. Nephron Exp. Nephrol. 2008; 110: e8-e16.
12. Wang G, Lai FM, Lai KB, et al,. Discrepancy between intrarenal messenger RNA and protein expression of ACE and ACE2 in human diabetic nephropathy. Am. J. Nephrol. 2009; 29: 524-31.
13. Levey AS, Eckardt KU, Tsukamoto Y, et al,. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005; 67: 2089-100. (Pubitemid 41623371)
14. Ferrario CM,. ACE2: More of Ang-(1-7) or less Ang II ? Curr. Opin. Nephrol. Hypertens. 2011; 20: 1-6.
15. Mizuiri S, Hemmi H, Arita M, et al,. Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls. Am. J. Kidney Dis. 2008; 5: 613-23. (Pubitemid 351400834)
16. Matsuo S, Imai E, Horio M, et al,. Revised equations for estimated GFR from serum creatinine in. Jpn. Am. J. Kidney Dis. 2009; 53: 982-92.
17. Reich HN, Oudit GY, Penninger JM, Scholey JW, Herzenberg AM,. Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease. Kidney Int. 2008; 74: 1610-6.
18. Lambert DW, Yarski M, Warner FJ, et al,. Tumor necrosis factor-alpha convertase (ADAM 17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J. Biol. Chem. 2005; 280: 30113-9. (Pubitemid 41216188)
19. Melenhorst WB, Visser L, Timmer A, van den Heuvel MC, Stegeman CA, van Goor H,. ADAM17 upregulation in human renal disease: A role in modulating TGF-alpha availability? Am. J. Physiol. Renal. Physiol. 2009; 297: F781-F790.
20. Rice GI, Jones AL, Grant PJ, Carter AM, Turner AJ, Hooper NM,. Circulating activities of angiotensin-converting enzyme, its homolog, angiotensin-converting enzyme 2, and neprilysin in a family study. Hypertension 2006; 48: 914-20. (Pubitemid 44611005)
21. Jia HP, Look DC, Tan P, et al,. Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia. Am. J. Physiol. Lung Cell Mol. Physiol. 2009; 297: L84-L96.
22. Casarini DE, Plavinik FL, Zanella MT, et al,. Angiotensin converting enzymes from human urine of mild hypertensive untreated patients resemble the N-terminal fragment of human angiotensin I-converting enzyme. Int. J. Biochem. Cell Biol. 2001; 33: 75-85. (Pubitemid 32146469)
23. Wong DW, Oudit GY, Reich H, et al,. Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am. J. Pathol. 2007; 17: 438-51. (Pubitemid 47344677)
24. Soler MJ, Wysocki J, Ye M, Llovrras J, Kanwar Y, Battle D,. ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney Int. 2007; 72: 614-23. (Pubitemid 47312795)
25. Reddy AB, Ramana KV, Srivastava S, Bhatnagar A, Srivastava SK,. Aldose reductase regulates high glucose-induced ectodomain shedding of tumor necrosis factor (TNF)-alpha via protein kinase C-delta and TNF-alpha converting enzyme in vascular smooth muscle cells. Endocrinology 2009; 150: 63-74.
26. Tikellis C, Johnston CI, Forbes JM, et al,. Characterization of renalangiotensin- converting enzyme 2 in diabetic nephropathy. Hypertension 2003; 41: 392-7. (Pubitemid 36314606)
27. Ferrario CM, Jessup J, Gallagher PE, et al,. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors. Kidney Int. 2005; 68: 2189-96. (Pubitemid 43117793)
28. Jessup JA, Gallagher PE, Averill DB, et al,. Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats. Am. J. Physiol. Heart Circ. Physiol. 2006; 291: H2166-H2172.
29. Douglas GC, O'Bryan MK, Hedger MP, et al,. The novel angiotensin- converting enzyme (ACE) homolog, ACE2 is selectively expressed by adult Leydig cells of the testis. Endocrinology 2004; 145: 4703-11. (Pubitemid 39281464)
30. Oudit GY, Herzenberg AM, Kassiri Z, et al,. Loss of angiotensin- converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am. J. Pathol. 2006; 168: 1808-20. (Pubitemid 43825302)
31. Joyner J, Neves LA, Granger JP, et al,. Temporal-spatial expression of ANG-(1-7) and angiotensin-converting enzyme 2 in the kidney of normal and hypertensive pregnant rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007; 293: R169-R177. (Pubitemid 47092174)